Tumor Vaccine and Interferon Gamma in Treating Patients With Refractory Epithelial Ovarian Cancer

This study has been completed.

Study NCT00004032 Information provided by National Cancer Institute (NCI)

First Received: December 10, 1999 Last Updated: February 6, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given

Publications:

Freedman RS, Platsoucas CD, Scholm J, et al.: Infection of fresh epithelial ovarian carcinoma (EOC) cells with a canarypox construct ALVAC-hB7.1 after in vitro treatment with rIFN-gamma and early clincial results. [Abstract] Proc Am Assoc Cancer Res 40: A3792, 1999.